Mindfulness and relaxation training occupy an odd position in migraine care. They are frequently recommended, rarely explained in detail, and easy to dismiss as soft interventions offered to patients when a clinician has run out of pharmacological options. That framing undersells what the research actually shows. Behavioral interventions targeting the nervous system's stress response have a genuine, measurable evidence base in migraine prevention, and for some people the effect size rivals that of established preventive medications.
Understanding what these interventions actually involve, and what the evidence supports, separates them from generic wellness advice and positions them as a legitimate component of a migraine treatment plan.
Mindfulness-based stress reduction is a structured program, typically delivered over eight weeks, that combines meditation, body awareness practices, and gentle movement to train sustained, non-judgmental attention to present-moment experience. It was developed originally for chronic pain and has since been studied across a range of conditions including migraine.
A randomized controlled trial published in Headache found that participants who completed a mindfulness-based stress reduction program experienced significant reductions in migraine severity, headache-related disability, and self-efficacy compared to a control group, though the effect on raw attack frequency was more modest than the effect on the disability and quality-of-life measures. This pattern, in which mindfulness improves how migraine is experienced and coped with even when it does not dramatically reduce the number of attacks, is a recurring theme in the research and is clinically meaningful in its own right.
Relaxation training encompasses a range of techniques, most commonly progressive muscle relaxation, in which a person systematically tenses and releases muscle groups throughout the body to reduce overall physiological arousal. Diaphragmatic breathing and guided imagery are also commonly included under this umbrella.
Relaxation training has one of the longer research histories among behavioral migraine interventions. A landmark trial published in Cephalalgia compared relaxation training to regular aerobic exercise and to the preventive medication topiramate and found that all three interventions produced comparable, clinically significant reductions in monthly migraine days. That relaxation training performed comparably to an established preventive medication in a controlled trial is one of the more striking findings in the behavioral migraine literature.
Biofeedback uses real-time physiological monitoring, most commonly of skin temperature or muscle tension, to help a person learn to consciously influence processes that are normally automatic. Thermal biofeedback trains increased peripheral hand temperature, which reflects reduced sympathetic nervous system activation. Electromyographic biofeedback trains reduced muscle tension, particularly in the head, neck, and shoulders.
A meta-analysis of biofeedback for headache disorders found consistent evidence for reduced migraine frequency, with effects that were durable at follow-up assessments conducted months after treatment ended. Biofeedback requires specialized equipment and trained providers, which can limit access relative to mindfulness or relaxation training, though home biofeedback devices have become more widely available in recent years.
Direct comparisons between behavioral interventions and pharmacological prevention are limited but informative where they exist. The Cephalalgia trial comparing relaxation training, aerobic exercise, and topiramate found comparable efficacy across all three arms. This does not mean behavioral interventions are interchangeable with medication for everyone. Response to any given migraine treatment, behavioral or pharmacological, varies considerably between individuals, and the trials that exist involve modest sample sizes relative to large pharmaceutical trials.
What the evidence does support is that behavioral interventions are not a lesser or purely supportive category of treatment. The American Headache Society includes behavioral interventions, including cognitive behavioral therapy, biofeedback, and relaxation training, as evidence-based options with grade A or B evidence in its treatment guidelines, placing them alongside many pharmacological preventive options in terms of evidence quality.
For many people with migraine, the most effective approach combines behavioral and pharmacological interventions rather than choosing one over the other. Research examining combined treatment, for example pairing preventive medication with relaxation training or biofeedback, has found evidence of additive benefit in some studies, meaning the combination outperforms either approach used alone.
Behavioral interventions may be particularly valuable for people whose migraine has a strong stress-related component, for those who wish to minimize medication use, for pregnant women and others for whom medication options are limited, and as an adjunct for people whose migraine remains inadequately controlled despite appropriate pharmacological treatment.
Unlike medication, behavioral interventions require an investment of time and practice before their effects become apparent, and consistency matters. Mindfulness-based stress reduction programs typically run over eight weeks with regular home practice. Relaxation training and biofeedback similarly benefit from regular practice over weeks to months rather than occasional use.
Access varies by location and insurance coverage. Structured programs and biofeedback are more available through headache clinics, behavioral medicine practices, and increasingly through app-based platforms and telehealth. For people considering these interventions, discussing options with a treating neurologist or headache specialist, who can help identify appropriately trained providers, is a reasonable starting point.
Wells RE, Burch R, Paulsen RH, et al. Meditation for migraines: a pilot randomized controlled trial. Headache. 2014.
Varkey E, Cider A, Carlsson J, Linde M. Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalalgia. 2011.
Nestoriuc Y, Martin A, Rief W, Andrasik F. Biofeedback treatment for headache disorders. Applied Psychophysiology and Biofeedback. 2008.
American Headache Society. Position Statement on Integrating New Migraine Treatments into Clinical Practice. Headache. 2019.
American Migraine Foundation. Relaxation and Migraine. americanmigrainefoundation.org
Magnesium, riboflavin, coenzyme Q10, omega-3 fatty acids, and dietary patterns — what clinical trial evidence actually supports.
How pregnancy affects migraine, which medications are relatively safe, which to avoid, and the importance of planning before and during pregnancy.
The neurological mechanism of dehydration-related migraine, the European Journal of Neurology water intake trial, and electrolyte considerations.
How pediatric migraine differs from adult migraine, migraine variants in children, treatment options, and the role of school and family.
Tracking your migraines changes everything. MigraClarity helps you log attacks, identify triggers, monitor medications, and track sleep and hydration — then generates a provider-ready report you can bring to your next appointment. Create your free account and start building a clearer picture of your migraine pattern today.
Create Your Free AccountThe information in this article is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional or licensed physician before making any decisions about your health, medications, or treatment. MigraClarity is not a medical provider and nothing on this site should be used as a substitute for professional medical care.